San Diego, CA, United States of America

Stephen R Johannsen

USPTO Granted Patents = 5 

Average Co-Inventor Count = 11.0

ph-index = 4

Forward Citations = 51(Granted Patents)


Company Filing History:


Years Active: 2014-2023

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Stephen R Johannsen

Introduction

Stephen R Johannsen is a notable inventor based in San Diego, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptor pathways. With a total of five patents to his name, Johannsen's work is recognized for its potential impact on various medical conditions.

Latest Patents

Johannsen's latest patents include processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and its salts. This invention relates to processes and intermediates that are useful in the preparation of this compound, which acts as an S1P1 receptor modulator. The compound is particularly relevant for treating S1P1 receptor-associated disorders, including diseases mediated by lymphocytes, transplant rejection, autoimmune diseases, inflammatory conditions, and cancer.

Career Highlights

Stephen R Johannsen is currently employed at Arena Pharmaceuticals, Inc., where he continues to innovate and develop new therapeutic solutions. His work has been instrumental in advancing the understanding and treatment of complex medical conditions.

Collaborations

Johannsen has collaborated with notable colleagues, including Antonio Garrido Montalban and Daniel J Buzard, contributing to a dynamic research environment that fosters innovation.

Conclusion

Stephen R Johannsen's contributions to pharmaceutical innovations highlight his expertise and commitment to improving healthcare outcomes. His patents reflect a deep understanding of complex biological systems and a dedication to addressing significant medical challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…